Editorial comment on 'A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy' by Schmitt et al.

Author: Hayward R.L.   Smyth J.F.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.17, 2002-11, pp. : 2207-2209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract